NASDAQ:HLTH - Nasdaq - US2297901009 - Common Stock - Currency: USD
0.0434
-0.02 (-29.77%)
The current stock price of HLTH is 0.0434 USD. In the past month the price decreased by -67.85%. In the past year, price decreased by -91.7%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Cue Health, Inc. is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care. The company is headquartered in San Diego, California and currently employs 1,515 full-time employees. The company went IPO on 2021-09-24. The firm is engaged in providing individuals with a connected diagnostic platform that bridges the physical and virtual care continuum. Its platform, Cue Integrated Care Platform, which consists of hardware, software and diagnostic components: the Cue Health Monitoring System, which is made up of a portable, durable and reusable reader, or Cue Reader, a single-use test cartridge, or Cue Cartridge, and a sample collection wand, or Cue Wand; Cue Data and Innovation Layer, with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, including its app and Cue Enterprise Dashboard, and its Cue Ecosystem Integrations and apps, which allow for integrations with third party applications and sensors. Its products include Cue Reader, COVID-19 Test, Cue Test Kits, Cue Care, and Cue+ Membership. The company offers solutions for home/personal, business, public sector, healthcare, retail pharmacies, entertainment and education sectors.
CUE HEALTH INC
4980 Carroll Canyon Road, Suite 100
San Diego CALIFORNIA 77079 US
CEO: Ayub Khattak
Employees: 1515
Company Website: https://cuehealth.com/
Phone: 18584128151
The current stock price of HLTH is 0.0434 USD. The price decreased by -29.77% in the last trading session.
The exchange symbol of CUE HEALTH INC is HLTH and it is listed on the Nasdaq exchange.
HLTH stock is listed on the Nasdaq exchange.
6 analysts have analysed HLTH and the average price target is 0.51 USD. This implies a price increase of 1075.12% is expected in the next year compared to the current price of 0.0434. Check the CUE HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CUE HEALTH INC (HLTH) has a market capitalization of 6.90M USD. This makes HLTH a Nano Cap stock.
CUE HEALTH INC (HLTH) currently has 1515 employees.
The Revenue of CUE HEALTH INC (HLTH) is expected to decline by -18.38% in the next year. Check the estimates tab for more information on the HLTH EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
HLTH does not pay a dividend.
CUE HEALTH INC (HLTH) will report earnings on 2024-08-07, after the market close.
CUE HEALTH INC (HLTH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.56).
ChartMill assigns a fundamental rating of 3 / 10 to HLTH. While HLTH seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months HLTH reported a non-GAAP Earnings per Share(EPS) of -2.56. The EPS decreased by -153.47% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -109.92% | ||
ROE | -149.25% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 43% to HLTH. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 56.3% and a revenue growth -18.38% for HLTH